[1] Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Li Y, Wang Y, Chen Z, Wu S, Zhang Y, Wang D, Wang Y, Feigin VL; NESS-China Investigators. Prevalence, incidence, and mortality of stroke in China:results from a nationwide population-based survey of 480687 adults[J]. Circulation, 2017, 135:759-771.
[2] Wang D, Liu J, Liu M, Lu C, Brainin M, Zhang J. Patterns of stroke between university hospitals and nonuniversity hospitals in mainland China:prospective multicenter hospital-based registry study[J]. World Neurosurg, 2017, 98:258-265.
[3] Hao ZL, Liu M, Li W, Tan Y, Zhang YH, Wu LE, Zhao XL, Yang J, Wang QF, Tan S, Yang QW, Wu B, Wang LC. Basic characteristics and functional outcomes of 3123 consecutive patients in Chengdu stroke registry[J]. Zhonghua Shen Jing Ke Za Zhi, 2011, 44:826-831[.郝子龙, 刘鸣, 李伟, 谭燕, 张月辉,吴丽娥, 赵晓玲, 杨杰, 王清芳, 谈颂, 阳清伟, 吴波, 王丽春.成都卒中登记方法及3123例患者基本特征和功能结局[J].中华神经科杂志, 2011, 44:826-831.]
[4] Wang Z, Li J, Wang C, Yao X, Zhao X, Wang Y, Li H, Liu G, Wang A, Wang Y. Gender differences in 1-year clinical characteristics and outcomes after stroke:results from the China National Stroke Registry[J]. PLoS One, 2013, 8:e56459.
[5] Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke:literature review and implications for clinical practice[J]. Arch Phys Med Rehabil, 1992, 73(5-S):S379-391.
[6] Correction to:2018 guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2018, 49:e138.
[7] Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke[J]. Cochrane Database Syst Rev, 2015:IDCD000024.
[8] Wang Y, Shi Y, Dong Y, Dong Q, Ye T, Fang K. Clinical risk factors of asymptomatic deep venous thrombosis in patients with acute stroke[J]. Clin Appl Thromb Hemost, 2019, 25:1076029619868534.
[9] Stuck AK, Spirk D, Schaudt J, Kucher N. Risk assessment models for venous thromboembolism in acutely ill medical patients:a systematic review[J]. Thromb Haemost, 2017, 117:801-808.
[10] Liu LP, Zheng HG, Wang DZ, Wang YL, Hussain M, Sun HX, Wang AX, Zhao XQ, Dong KH, Wang CX, He W, Ning B, Wang YJ. Risk assessment of deep-vein thrombosis after acute stroke:a prospective study using clinical factors[J]. CNS Neurosci Ther, 2014, 20:403-410.
[11] Balogun IO, Roberts LN, Patel R, Pathansali R, Kalra L, Arya R. Clinical and laboratory predictors of deep vein thrombosis after acute stroke[J]. Thromb Res, 2016, 142:33-39.
[12] Li SY, Feng L, Xiao MJ, Chen SY, He JC, Wang Z. Derivation and validation of a clinical prediction scale for isolated distal deep venous thrombosis in patients after acute ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2017, 26:2087-2092.
[13] Neurology Branch of Chinese Medical Association, Cerebrovascular Disease Group of Neurology Branch of Chinese Medical Association. Diagnostic criteria of cerebrovascular diseases in China (version 2019)[J]. Zhonghua Shen Jing Ke Za Zhi, 2019, 52:710-715[.中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国各类主要脑血管病诊断要点2019[J]. 中华神经科杂志, 2019, 52:710-715.]
[14] Righini M, Le Gal G, Bounameaux H. Venous thromboembolism diagnosis:unresolved issues[J]. Thromb Haemost, 2015, 113:1184-1192.
[15] Xie WM, Wang C. The diagnosis ideas and treatment strategies of pulmonary thromboembolism:respiratory diseases (2)[J]. Xin Yi Xue, 2005, 36:547-548[.谢万木, 王辰. 肺血栓栓塞症的诊断思路与治疗策略——呼吸系统疾病(2)[J]. 新医学, 2005, 36:547-548.]
[16] Kong XL, Zhang X, Zhang SJ, Zhang L. Plasma level of D-dimer is an independent diagnostic biomarker for deep venous thrombosis in patients with ischemic stroke[J]. Curr Neurovasc Res, 2016, 13:100-106.
[17] Kelly J, Rudd A, Lewis RR, Parmar K, Moody A, Hunt BJ. The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness[J]. Blood Coagul Fibrinolysis, 2003, 14:639-645.